July 19


ZURICH, July 19, 2011 - Kuros Biosurgery AG, a biotechnology company focused on the development of novel biomaterials and bioactive-biomaterial combination products for trauma, wound and spinal indications, announced today that it has received Notice of Allowance for U.S.

CAMBRIDGE, England, July 19, 2011 - Convergence Pharmaceuticals Limited ("Convergence"), the company focused on the development of novel and high value analgesic medicines, today announces that the Phase II proof of concept study with CNV1014802 for treating pain associated with lumbosacral radiculopathy (LSR) has started.

ANN ARBOR, Michigan, July 19, 2011 - Terumo Heart, Inc., a wholly owned subsidiary of Terumo Corporation, today announced that a patient implanted with the DuraHeart™ Left Ventricular Assist System (LVAS) has surpassed five years of support on the mechanical circulatory support device.

TOKYO, July 19, 2011 - -- First Direct Oral Factor Xa Inhibitor Available to Japanese Patients -- Building on its cardiovascular portfolio, Daiichi Sankyo Company, Limited (hereafter, Daiichi Sankyo), is proud to announce the launch of LIXIANA (JAN: Edoxaban Tosilate Hydrate, INN: edoxaban) in Japan.

LONDON, July 19, 2011 - ITN Productions is partnering with Rightster to bring to a mass online audience live video coverage of the historic UK Parliamentary hearing into the on-going News International phone hacking scandal.
Older News
S M T W T F S
3 4 5 6 7 8 9
10 11 12 13 14 15 16
17 18 19 20 21 22 23
Copyright© 2011 The Gaea Times